SCHEMBL1307702

SCHEMBL1307702

[c]1cccc2nnnnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10411858 0.71
SCHEMBL3831848 0.71
SCHEMBL26373 0.67 ALDH1A1 (0.56)
SCHEMBL5778283 0.67
SCHEMBL3831840 0.67
SCHEMBL31311 0.67 MAPT (0.39)
SCHEMBL1395713 0.67
SCHEMBL25712 0.67 MAPT (0.52)
SCHEMBL395977 0.67 MAPT (0.50)
SCHEMBL231554 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056354-B2 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibers L'OREAL (FR) 2006-06-06 US claimed
US-20040255397-A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers L'OREAL (FR) 2004-12-23 US claimed
US-6740655-B2 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 4-SPECIFIC INHIBITORS REDUCE EOSINOPHIL INFLUX TO THE LUNGS; SIDE EFFECT REDUCTION; ANTIINFLAMMATORY AGENT; ANTIALLERGENS; RESPIRATORY SYSTEM DISORDERS, ESPECIALLY ASTHMA PFIZER INC 2004-05-25 US claimed
US-20030144300-A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes PFIZER PRODUCTS INC. 2003-07-31 US claimed
US-20020169203-A1 Ion channel modulating agents NEUROSEARCH A/S (DK) 2002-11-14 US claimed
EP-1252157-A1 PYRIMIDINE CARBOXAMIDES USEFUL AS INHIBITORS OF PDE4 ISOZYMES Pfizer Products Inc. (US) 2002-10-30 EP claimed
EP-1140784-A2 ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2001-10-10 EP claimed
WO-2001057025-A1 PYRIMIDINE CARBOXAMIDES USEFUL AS INHIBITORS OF PDE4 ISOZYMES PFIZER PRODUCTS INC. (US) 2001-08-09 WO claimed
WO-2000037422-A2 ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2000-06-29 WO claimed
CN-118201913-A Process for producing 2-heteroarylpyridine compound 日本曹达株式会社 2024-06-14 CN disclosed
CN-118139853-A Process for producing 2-heteroarylpyridine compound 日本曹达株式会社 2024-06-04 CN disclosed
WO-2023090337-A1 METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND 日本曹達株式会社 2023-05-25 WO disclosed
WO-2023090344-A1 METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND 日本曹達株式会社 2023-05-25 WO disclosed
CN-110799868-B Liquid crystal film, optical laminate, circularly polarizing plate, and organic electroluminescent display device 富士胶片株式会社 2022-02-22 CN disclosed
US-20020169203-A1 Ion channel modulating agents NEUROSEARCH A/S (DK) 2002-11-14 US disclosed
EP-1252157-A1 PYRIMIDINE CARBOXAMIDES USEFUL AS INHIBITORS OF PDE4 ISOZYMES Pfizer Products Inc. (US) 2002-10-30 EP disclosed
US-20020013336-A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases NEUROSEARCH A/S (DK) 2002-01-31 US disclosed
WO-2001057025-A1 PYRIMIDINE CARBOXAMIDES USEFUL AS INHIBITORS OF PDE4 ISOZYMES PFIZER PRODUCTS INC. (US) 2001-08-09 WO disclosed
EP-0231244-A1 6-ALKYLIDENE PENEMS BEECHAM GROUP PLC (GB) 1987-08-12 EP disclosed
WO-1987000525-A1 6-ALKYLIDENE PENEMS BEECHAM GROUP P.L.C. (GB) 1987-01-29 WO disclosed